0

Sequencing Reagents Market by Technology and Geography - Forecast and Analysis 2022-2026

  • Published: Feb 2022
  • Pages: 120
  • SKU: IRTNTR72545
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The sequencing reagents market share is expected to increase by USD 4.09 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.32%.

This sequencing reagents market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers sequencing reagents market segmentation by technology (next-generation sequencing, sanger sequencing, and third generation sequencing) and geography (North America, Europe, Asia, and Rest of World (ROW)). The sequencing reagents market report also offers information on several market vendors, including Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Meridian Bioscience Inc, New England Biolabs Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc., Tecan Group Ltd., Trilink Biotechnologies, Merck KGaA, Pacific Biosciences of California Inc., and Takara Bio Inc. among others.

What will the Sequencing Reagents Market Size be During the Forecast Period?

Sequencing Reagents Market Size

Download the Free Report Sample to Unlock the Sequencing Reagents Market Size for the Forecast Period and Other Important Statistics

 

Sequencing Reagents Market: Key Drivers, Trends, and Challenges

The increasing affordability of DNA sequencing is notably driving the sequencing reagents market growth, although factors such as inadequate resources for DNA sequencing in developing countries may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the sequencing reagents industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Sequencing Reagents Market Driver

The increasing affordability of DNA sequencing is one of the key drivers supporting the sequencing reagents market growth. In the past, the cost structure for sequencing reagents involved a lot of ambiguity as it was measured in terms of $/base, which made it unclear if the cost included the different steps involved in sequencing or just the sequencing run. Thus, as a solution to this problem, a new all-inclusive approach was developed. This all-inclusive cost structure includes the cost of components, direct costs, and indirect costs associated with a sequencing project. This approach provides better insights into the cost structure of a sequencing project and aids end-users and funding agencies in improving their research plans. These factors are likely to make DNA sequencing more accessible and affordable to a much larger population, which, in turn, is expected to drive the global sequencing reagents market during the forecast period.

Key Sequencing Reagents Market Trend

Advances in next-generation sequencing techniques is another factor supporting the sequencing reagents market growth. The rising number of research activities and discoveries in genetic testing for determining genetic variants has enabled the vendors, such as Bio-Rad Laboratories and Eurofins, to offer a wide variety of prediction tests for blood sugar regulation, cancer, vision loss, and autoimmune disorders is boosting the demand for sequencing reagents. In addition, the widespread adoption of DNA biochips in genetic testing and research, owing to its integration and miniaturization benefits, has accelerated the identification of 78,000-80,000 genes in human DNA. This has been done by enabling the performance of DNA microarray tests and gene decoding-based biological reactions using a single chip. The development of such advanced technologies has helped to reduce the cost of testing as well as the turnaround time. Such technologies are driving market growth.

Key Sequencing Reagents Market Challenge

The inadequate resources for DNA sequencing in developing countries is one of the factors hindering the sequencing reagents market growth. DNA sequencing is an interdisciplinary field that requires knowledge in bioinformatics, chemistry, and biology. Hence, workers who perform DNA sequencing need specialized training in this field. However, limited human development and education capacities in developing countries lead to insufficient training. Furthermore, genomic data analysis and manipulation have become essential tools for genomic research. Even though some tools are distributed under open-source licenses, the use of many advanced tools still requires the payment of licensure fees, which are often beyond the financial capabilities of many institutions in developing countries. Hence, the availability of limited resources such as sequencing reagents for DNA sequencing in developing countries is a major challenge for market growth.

This sequencing reagents market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global sequencing reagents market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the sequencing reagents market during the forecast period.

Who are the Major Sequencing Reagents Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Agilent Technologies Inc.
  • BGI Group
  • BioChain Institute Inc.
  • F. Hoffmann La Roche Ltd.
  • Fluidigm Corp.
  • FroggaBio Inc.
  • Illumina Inc.
  • LGC Biosearch Technologies
  • Meridian Bioscience Inc
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies plc
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Tecan Group Ltd.
  • Trilink Biotechnologies
  • Merck KGaA
  • Pacific Biosciences of California Inc.
  • Takara Bio Inc.

 

This statistical study of the sequencing reagents market encompasses successful business strategies deployed by the key vendors. The sequencing reagents market is fragmented and the vendors are deploying growth strategies such as pricing strategies and low-cost customization options to compete in the market.

Product Insights and News

  • Roche.com - The company offers sarcoma therapeutics products under the brand name of Tibsovo.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The sequencing reagents market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Sequencing Reagents Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the sequencing reagents market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Sequencing Reagents Market?

Sequencing Reagents Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for sequencing reagents market in North America. Market growth in this region will be faster than the growth of the market in ROW.

The increased focus on gene therapy and national initiatives in developing personalized medicines will facilitate the sequencing reagents market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 adversely affected the market in North America. As of November 19, 2021, several countries in North America were compelled to impose lockdowns to contain the spread of the disease. However, assessing the core next-generation sequencing features in regional populations can be used for comparative analysis to identify unique features of SARS-CoV-2 and assist in epidemiologic and public health endeavors. Such factors have increased the demand for next-generation sequencing products and services such as sequencing reagents in the region in 2021, which, in turn, is expected to drive the regional market growth

What are the Revenue-generating Technology Segments in the Sequencing Reagents Market?

Sequencing Reagents Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The sequencing reagents market share growth by the next-generation sequencing segment will be significant during the forecast period. Next-generation sequencing, fragments a high-throughput sequencing, is a powerful platform that enables simultaneous sequencing of millions of deoxyribonucleic acid (DNA) fragments. The advent of the next-generation sequencing market has revolutionized research across various fields by offering sequencing with high-speed, low-cost, and shorter turnaround times when compared to sanger sequencing. The demand for sequencing reagents in next-generation sequencing is growing due to the effectiveness of next-generation sequencing. Hence, their demand is expected to grow during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the sequencing reagents market size and actionable market insights on post COVID-19 impact on each segment.

You may be interested in:

Blood-grouping Reagents market - The market share is expected to increase by USD 485.33 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.19%.

DNA Sequencing market - The market share from 2021 to 2026 is USD 23.56 billion at a progressing CAGR of 20.85%.

Sequencing Reagents Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.32%

Market growth 2022-2026

$ 4.09 billion

Market structure

Fragmented

YoY growth (%)

11.54

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Meridian Bioscience Inc, New England Biolabs Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc., Tecan Group Ltd., Trilink Biotechnologies, Merck KGaA, Pacific Biosciences of California Inc., and Takara Bio Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Sequencing Reagents Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive sequencing reagents market growth during the next five years
  • Precise estimation of the sequencing reagents market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the sequencing reagents industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of sequencing reagents market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Technology

    • 5.1 Market segments
      • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
    • 5.2 Comparison by Technology
      • Exhibit 26: Chart on Comparison by Technology
      • Exhibit 27: Data Table on Comparison by Technology
    • 5.3 Next-generation sequencing - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Next-generation sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Next-generation sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Next-generation sequencing - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Next-generation sequencing - Year-over-year growth 2021-2026 (%)
    • 5.4 Sanger sequencing - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Sanger sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Sanger sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Sanger sequencing - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Sanger sequencing - Year-over-year growth 2021-2026 (%)
    • 5.5 Third generation sequencing - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Third generation sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Third generation sequencing - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Third generation sequencing - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Third generation sequencing - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Technology
      • Exhibit 40: Market opportunity by Technology ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 Canada - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 UK - Market size and forecast 2021-2026
      • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 Agilent Technologies Inc.
              • Exhibit 89: Agilent Technologies Inc. - Overview
              • Exhibit 90: Agilent Technologies Inc. - Business segments
              • Exhibit 91: Agilent Technologies Inc. - Key news
              • Exhibit 92: Agilent Technologies Inc. - Key offerings
              • Exhibit 93: Agilent Technologies Inc. - Segment focus
            • 10.4 BGI Group
              • Exhibit 94: BGI Group - Overview
              • Exhibit 95: BGI Group - Product / Service
              • Exhibit 96: BGI Group - Key offerings
            • 10.5 F. Hoffmann La Roche Ltd.
              • Exhibit 97: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 98: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 99: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 100: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 101: F. Hoffmann La Roche Ltd. - Segment focus
            • 10.6 Fluidigm Corp.
              • Exhibit 102: Fluidigm Corp. - Overview
              • Exhibit 103: Fluidigm Corp. - Business segments
              • Exhibit 104: Fluidigm Corp. - Key news
              • Exhibit 105: Fluidigm Corp. - Key offerings
              • Exhibit 106: Fluidigm Corp. - Segment focus
            • 10.7 Illumina Inc.
              • Exhibit 107: Illumina Inc. - Overview
              • Exhibit 108: Illumina Inc. - Product / Service
              • Exhibit 109: Illumina Inc. - Key offerings
            • 10.8 Oxford Nanopore Technologies plc
              • Exhibit 110: Oxford Nanopore Technologies plc - Overview
              • Exhibit 111: Oxford Nanopore Technologies plc - Product / Service
              • Exhibit 112: Oxford Nanopore Technologies plc - Key offerings
            • 10.9 Pacific Biosciences of California Inc.
              • Exhibit 113: Pacific Biosciences of California Inc. - Overview
              • Exhibit 114: Pacific Biosciences of California Inc. - Product / Service
              • Exhibit 115: Pacific Biosciences of California Inc. - Key offerings
            • 10.10 QIAGEN NV
              • Exhibit 116: QIAGEN NV - Overview
              • Exhibit 117: QIAGEN NV - Business segments
              • Exhibit 118: QIAGEN NV - Key news
              • Exhibit 119: QIAGEN NV - Key offerings
              • Exhibit 120: QIAGEN NV - Segment focus
            • 10.11 Takara Bio Inc.
              • Exhibit 121: Takara Bio Inc. - Overview
              • Exhibit 122: Takara Bio Inc. - Product / Service
              • Exhibit 123: Takara Bio Inc. - Key offerings
            • 10.12 Thermo Fisher Scientific Inc.
              • Exhibit 124: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 125: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 126: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 128: Thermo Fisher Scientific Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 129: Inclusions checklist
                • Exhibit 130: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 131: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 132: Research methodology
                • Exhibit 133: Validation techniques employed for market sizing
                • Exhibit 134: Information sources
              • 11.5 List of abbreviations
                • Exhibit 135: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Sequencing Reagents market growth will increase by $4097.59 million during 2021-2026.
              The sequencing reagents market is expected to grow at a CAGR of 12.32% during 2021-2026.
              Technavio has segmented the sequencing reagents market by technology (Next-generation sequencing, Sanger sequencing, and Third generation sequencing) and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Agilent Technologies Inc., BGI Group, BioChain Institute Inc., F. Hoffmann La Roche Ltd., Fluidigm Corp., FroggaBio Inc., Illumina Inc., LGC Biosearch Technologies, Meridian Bioscience Inc, New England Biolabs Inc., Oxford Nanopore Technologies plc, PerkinElmer Inc., QIAGEN NV, Thermo Fisher Scientific Inc., Tecan Group Ltd., Trilink Biotechnologies, Merck KGaA, Pacific Biosciences of California Inc., Takara Bio Inc. are a few of the key vendors in the sequencing reagents market.
              North America will register the highest growth rate of 39.33% among the other regions. Therefore, the sequencing reagents market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the sequencing reagents market growth are:
              • Increasing affordability of DNA sequencing
              • Advances in next generation sequencing techniques
              The sequencing reagents market vendors should focus on grabbing business opportunities from the next-generation sequencing segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>